VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DWTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DWTXDogwood Therapeutics, Inc.
$1.78$60M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDWTXQuarterly Financials

Dogwood Therapeutics, Inc. (DWTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Dogwood Therapeutics, Inc. (DWTX) quarterly income statement — complete revenue, gross profit & net income history

DWTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses5.08M3.81M15.81M3.92M4.43M7.54M2.3M1.07M1.31M1.14M1.27M1.48M1.56M2.09M2.59M3.67M3.96M4.19M4.11M4.28M
OpEx % of Revenue--------------------
Selling, General & Admin2.41M1.47M1.29M1.35M1.99M5.23M1.77M733.74K970.38K839.8K900.09K919.37K1.06M818K969.95K1.27M1.19M1.27M1.15M1.08M
SG&A % of Revenue--------------------
Research & Development2.67M2.34M14.52M2.57M2.44M2.32M535.16K336.08K343.72K298.32K374.2K557.84K497.71K1.27M1.62M2.41M2.77M2.92M2.96M3.21M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-5.08M-3.81M-15.81M-3.92M-4.43M-7.54M-2.3M-1.07M-1.31M-1.14M-1.27M-1.48M-1.56M-2.09M-2.59M-3.67M-3.96M-4.19M-4.11M-4.28M
Operating Margin %--------------------
Operating Income Growth %-14.59%49.53%-587%-266.71%-237.11%-562.68%-80.58%27.58%15.62%45.54%50.84%59.77%60.69%50.1%36.95%14.29%-29.56%34.79%-54.4%-695.81%
EBITDA-5.08M-3.81M-15.79M-3.91M-4.41M-7.57M-2.3M-1.07M-1.31M-1.14M-1.27M-1.48M-1.56M-2.09M-2.59M-3.67M-3.96M-4.19M-4.11M-4.28M
EBITDA Margin %--------------------
EBITDA Growth %-15.03%49.74%-586.25%-265.09%-235.81%-565.39%-80.58%27.58%15.62%45.54%50.84%59.77%60.69%50.1%36.95%14.29%-29.56%34.79%-54.4%-695.81%
D&A (Non-Cash Add-back)0017.26K17.26K17.02K000000000000000
EBIT-5.08M-3.81M-15.75M-3.92M-4.43M-7.57M-2.3M-1.07M-1.31M-1.14M-1.27M-1.48M-1.56M-2.09M-2.59M-3.67M-3.96M-4.19M-4.11M-4.28M
Net Interest Income77.35K080.58K111.38K-147.09K-155.44K20.49K19.99K22.77K34.95K39.22K36.31K40.42K45.16K16.61K4.8K9061.27K1.51K1.5K
Interest Income77.35K080.58K111.38K0020.49K19.99K22.77K34.95K39.22K36.31K40.42K45.16K16.61K4.8K9061.27K1.51K1.5K
Interest Expense0000147.09K155.44K00000000000000
Other Income/Expense90.94K57.67K63.07K115.91K-6.3M-186.22K20.49K19.99K22.77K34.95K39.22K36.31K40.42K45.16K16.61K4.8K906-323.73K1.51K1.5K
Pretax Income-4.99M-3.75M-15.75M-3.81M-10.73M-7.73M-2.28M-1.05M-1.29M-1.1M-1.24M-1.44M-1.52M-2.04M-2.58M-3.67M-3.96M-4.51M-4.11M-4.28M
Pretax Margin %--------------------
Income Tax-1.19K31.84K-1.44K149190.54K-50300000000000000
Effective Tax Rate %0.02%-0.85%0.01%-0%-1.78%0.01%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-4.99M-3.78M-15.74M-3.81M-10.92M-7.73M-2.28M-1.05M-1.29M-1.1M-1.24M-1.44M-1.52M-2.04M-2.58M-3.67M-3.96M-4.51M-4.11M-4.28M
Net Margin %--------------------
Net Income Growth %54.36%51.08%-590.35%-262.66%-746.02%-600.51%-84.66%27.14%14.87%46.04%52.05%60.71%61.7%54.68%37.33%14.38%-29.59%30.61%-50.88%-554.3%
Net Income (Continuing)-4.98M-3.78M-15.74M-3.81M-10.92M-7.73M-2.28M-1.05M-1.29M-1.1M-1.24M-1.44M-1.52M-2.04M-2.58M-3.67M-3.96M-4.51M-4.11M-4.28M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.15-0.26-8.20-1.99-8.45-5.90-2.05-1.15-1.68-1.43-1.62-1.96-2.07-2.79-7.00-11.01-11.89-13.54-12.33-12.85
EPS Growth %98.22%95.59%-300%-73.04%-402.98%-312.59%-26.54%41.33%18.84%48.75%76.86%82.2%82.59%79.39%43.23%14.32%-29.52%56.57%11.68%-279.06%
EPS (Basic)-0.15-0.26-8.20-1.99-8.45-5.90-2.05-1.15-1.68-1.43-1.62-1.96-2.07-2.79-7.00-11.01-11.89-13.54-12.33-12.85
Diluted Shares Outstanding33.54M14.52M1.92M1.44M1.44M1.31M1.11M916.03K770.32K770.32K763.75K736.46K733.22K733.22K368K333.21K333.21K333.21K333.21K333.21K
Basic Shares Outstanding33.54M14.52M1.92M1.44M1.44M1.31M1.11M916.03K770.32K770.32K763.75K736.46K733.22K733.22K368K333.21K333.21K333.21K333.21K333.21K
Dividend Payout Ratio--------------------